Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 0.60 |
| ▸ | CA1 | P00915 | 8/20 | 0.60 |
| ▸ | CA2 | P00918 | 8/20 | 0.60 |
| ▸ | CA4 | P22748 | 3/20 | 0.60 |
| ▸ | CA5A | P35218 | 3/20 | 0.60 |
| ▸ | CA7 | P43166 | 3/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24086079 | 1.00 | CA12 (0.60) | CA12CA1CA2CA4CA5A | |
| SCHEMBL21851786 | 1.00 | CA12 (0.60) | CA12CA1CA2CA4CA5A | |
| SCHEMBL27169566 | 0.94 | CA12 (0.59) | CA12CA1CA2CA4CA5A | |
| SCHEMBL3490324 | 0.92 | CA12 (0.50) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18942038 | 0.91 | CA12 (0.51) | CA12CA1CA2CA4CA5A | |
| SCHEMBL20169037 | 0.90 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL17159594 | 0.90 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL22927973 | 0.90 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL1029421 | 0.90 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL23642758 | 0.90 | CA12 (0.72) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080249165-A1 | Glycosides and Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249165-A1 | Glycosides and Salts Thereof | AREG, MRGPRX2, IL33 | CA12 354/4885CA1 595/4885CA2 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.